投資家向けFAQ

よくある投資家からの質問とその答え

投資家向けFAQ

Questions

Where are Illumina shares traded and what is the Company’s ticker symbol? More Details  +
 

The Company’s common stock is traded on the NASDAQ Stock Market under the symbol ILMN.

What is Illumina’s CUSIP number for its common stock? More Details  +
 

The CUSIP number for Illumina’s common stock is 452327109.

What is Illumina’s CUSIP number for its convertible debt securities? More Details  +
 

Illumina has three convertible debt securities, which are as follows:

CUSIP number 452327AD1 with a maturity date of 3/15/2016;
CUSIP number 452327AE9 with a maturity date of 6/15/2019; and
CUSIP number 452327AG4 with a maturity date of 6/15/2021.

When did Illumina go public? At what price? More Details  +
 

Illumina went public on July 28, 2000 at a price of $16.00, or $8.00 on a split-adjusted basis.

When and where was Illumina incorporated? More Details  +
 

Illumina was incorporated in California in April 1998 and reincorporated in Delaware in July 2000.

What is Illumina’s vision? More Details  +
 

To advance human health by unlocking the power of the genome.

What is Illumina’s fiscal year-end? More Details  +
 

The Company's fiscal year is 52 or 53 weeks ending the Sunday closest to December 31, with quarters of 13 or 14 weeks ending the Sunday closest to March 31, June 30, September 30, and December 31.

Who is Illumina’s stock transfer agent? More Details  +
 

Computershare Trust Company, N.A. is Illumina’s stock transfer agent. Computershare contact information is as follows:

Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
Phone: 800.251.4215
Corporate Website: http://www.computershare.com

How can I buy Illumina’s stock? More Details  +
 
Illumina common stock can be bought or sold through a stockbroker, bank or financial institution that offers brokerage services.
Does Illumina issue dividends on its common stock and
have a Dividend Reinvestment Plan (DRIP)?
More Details  +
 

Illumina currently does not issue dividends and does not have a DRIP.

Has Illumina split its stock? More Details  +
 

Illumina split its stock on September 23, 2008 on a 2-for-1 basis.

When is Illumina’s Annual Meeting? More Details  +
 

Typically, the Company's annual meeting is held in May, but the date is subject to change at the discretion of the Board of Directors.

How may I obtain copies of Illumina’s financial information? More Details  +
 

Most of the Company's reports and financial filings can be printed or downloaded from the Financial Information section if this site.
Financial Information

How can I obtain copies of Illumina’s materials filed
with the Securities and Exchange Commission (SEC)?
More Details  +
 

Illumina’s SEC filings can be printed or downloaded from the SEC Filings section of this site.

SEC Filiings

When is Illumina’s next quarterly earnings conference call? More Details  +
 

Illumina’s upcoming earnings conference call information can be viewed on the Events & Presentations section of this site.

Events & Presentations

How many people does Illumina employ? More Details  +
 

Illumina has more than 3,750+ employees globally.

Who are Illumina’s independent auditors? More Details  +
 

Illumina’s independent auditors are Ernst & Young LLP.

How do I sign up to receive future shareholder publications? More Details  +
 

Future shareholder publications can be obtained by signing up on the E-mail Alerts section of this site.

Email Alerts

How do I contact Illumina’s Investor Relations? More Details  +
 

Illumina, Inc., Investors Relations
5200 Illumina Way
San Diego, CA 92122
Phone: 858.882.2080
E-mail: ir@illumina.com

ILMN(普通株式)

為替: NASDAQ GS (US Dollar)

価格: $210.67

前日比: $1.65 (0.78%)

量: 567,892

開始日: Nov 20 2017 4:00PM ET

 

At a Glance

  • 5-Year Revenue CAGR of 23%*
  • 5-Year Non-GAAP EPS CAGR of 28%*
  • $20 Billion Market Opportunity
  • 3,750+ Employees
  • *As of FY'14

 

Investor Tools

  Email Alerts
  Investor Relations Contact

 

Quick Links

Recent Investor Presentation
Quarterly Financial Report
Proxy
Form 10-K